{
    "trace": [
        {
            "role": "user",
            "content": [
                {
                    "type": "text",
                    "text": "Which of the following methods should be used to account for research and development costs with no alternative future use?\n\nA. Charging all costs to expense when incurred.\nB. Capitalizing all costs when incurred.\nC. Capitalizing costs specified by management and charging all other costs to expense.\nD. Accumulating all costs in a separate component of stockholders' equity until the existence of future benefits can be determined.\n"
                }
            ]
        },
        {
            "role": "assistant",
            "content": [
                {
                    "type": "text",
                    "text": "A. Charging all costs to expense when incurred.\n\nWhen there is no alternative future use for research and development costs, these expenses should be recognized immediately as they are not expected to generate future economic benefits. Therefore, they should be charged to the income statement in the period they are incurred. This alignss with the matching principle in accounting, which requires expenses to be matched with revenues in the same reporting period."
                }
            ]
        },
        {
            "role": "user",
            "content": [
                {
                    "type": "text",
                    "text": "Now, output the final answer and nothing else:"
                }
            ]
        },
        {
            "role": "assistant",
            "content": [
                {
                    "type": "text",
                    "text": "A"
                }
            ]
        }
    ],
    "final_answer": "A",
    "label": "A"
}